Results 161 to 165 of about 11,301 (165)
Some of the next articles are maybe not open access.
Cost-effectiveness of PCSK9 Inhibitor Therapy
JAMA, 2016Vera, Mastey, Bryan M, Johnstone
openaire +2 more sources
Dyslipidaemias, atherosclerosis and PCSK9 inhibitors
2018Pregledno predavanje o značaju dislipidemija u razvoju ateroskleroze, sadašnjoj standardnoj hipolipemičkoj terapiji u skladu s europskim smjernicama te novim mogućnostima prevencije ateroskleroze djelovanjem na LDL kolesterol PCSK9 inhibitorima.
openaire
PCSK9 Inhibitors Prior Authorization.
Circulation. Cardiovascular quality and outcomes, 2020Khurram, Nasir +2 more
openaire +1 more source

